Determination of Nebivolol and Valsartan in a Fixed-Dose Combination by Liquid ChromatographyDOSHI, Ashish S; BHAGWAN, Sushil S; MEHTA, Tushar N et al.Journal of AOAC International. 2008, Vol 91, Num 2, pp 292-298, issn 1060-3271, 7 p.Article

Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal womenFOGARI, Roberto; PRETI, Paola; ZOPPI, Annalisa et al.American journal of hypertension. 2004, Vol 17, Num 1, pp 77-81, issn 0895-7061, 5 p.Article

Validation of a Capillary Electrophoresis Method for the Simultaneous Determination of Amlodipine Besylate and Valsartan in Pharmaceuticals and Human PlasmaALNAJJAR, Ahmed O.Journal of AOAC International. 2011, Vol 94, Num 2, pp 498-502, issn 1060-3271, 5 p.Article

Étude de la tolérance du valsartan en cardiologie de ville chez 3197 hypertendus (étude VALSE) = Evaluation of the safety and efficacy of valsartan in office practice in 3 197 hypertensive patients (the Valse study)GHANNAD, E; FRANCILLON, A; VAILLANT, J et al.Annales de cardiologie et d'angéiologie (Paris). 2000, Vol 49, Num 1, pp 13-20, issn 0003-3928Article

Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities : The DETECTIV pilot study. CommentaryDUPREZ, Daniel A; FLOREA, Natalia D; JONES, Kathryn et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 9, pp 835-842, issn 0735-1097, 8 p.Article

High-Performance Liquid Chromatographic and First Derivative of the Ratio Spectrophotometric Determination of Amlodipine and Valsartan in Their Binary MixturesKUL, Dilek; DOGAN-TOPAL, Burcu; KUTUCU, Tugba et al.Journal of AOAC International. 2010, Vol 93, Num 3, pp 882-890, issn 1060-3271, 9 p.Article

Multinational economic evaluation of valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)REED, Shelby D; FRIEDMAN, Joëlle Y; VELAZQUEZ, Eric J et al.The American heart journal. 2004, Vol 148, Num 1, pp 122-128, issn 0002-8703, 7 p.Article

Determination of Azide and Bromide Ions by Direct Detection Using Capillary ElectrophoresisRAM REDDY, G. V; PRAVEEN KUMAR, A; VENKATESWARA REDDY, B et al.Journal of liquid chromatography & related technologies. 2009, Vol 32, Num 17-20, pp 2866-2878, issn 1082-6076, 13 p.Article

Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patientsEGUCHI, Kazuo; KARIO, Kazuomi; HOSHIDE, Yoko et al.American journal of hypertension. 2004, Vol 17, Num 2, pp 112-117, issn 0895-7061, 6 p.Article

Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signallingSU, Kuo-Hui; TSAI, Jin-Yi; YU RU KOU et al.Cardiovascular research. 2009, Vol 82, Num 3, pp 468-475, issn 0008-6363, 8 p.Article

Antihypertensive efficacy and tolerability of two fixed- dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension : An 8-week, randomized, double-blind, parallel-group trialLACOURCIERE, Yves; POIRIER, Luc; HEBERT, Daniel et al.Clinical therapeutics. 2005, Vol 27, Num 7, pp 1013-1021, issn 0149-2918, 9 p.Article

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance : Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) TrialCALIFF, Robert M; BOOLELL, Mitradev; HAFFNER, Steven M et al.The American heart journal. 2008, Vol 156, Num 4, pp 623-632, issn 0002-8703, 10 p.Article

Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophyYASUNARI, Kenichi; MAEDA, Kensaku; WATANABE, Takanori et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 11, pp 2116-2123, issn 0735-1097, 8 p.Article

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)BARUCH, Lawrence; GLAZER, Robert D; AKNAY, Nora et al.The American heart journal. 2004, Vol 148, Num 6, pp 951-957, issn 0002-8703, 7 p.Article

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureCOHN, Jay N; TOGNONI, Gianni.The New England journal of medicine. 2001, Vol 345, Num 23, pp 1667-1675, issn 0028-4793Article

Dose-response efficacy of valsartan, a new angiotensin II receptor blockerPOOL, J. L; GLAZER, R; CHIANG, Y.-T et al.Journal of human hypertension. 1999, Vol 13, Num 4, pp 275-281, issn 0950-9240Article

Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assayBELZ, G. G; BUTZER, R; KOBER, S et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 4, pp 367-373, issn 0009-9236Article

Enhanced angiotensin-mediated responses in the nucleus tractus solitarii of spontaneously hypertensive ratsKATSUNUMA, Nobuhide; TSUKAMOTO, Kazuyoshi; ITO, Satoru et al.Brain research bulletin. 2003, Vol 60, Num 3, pp 209-214, issn 0361-9230, 6 p.Article

Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)CALIFF, Robert M; LOKHNYGINA, Yuliya; VELAZQUEZ, Eric J et al.The American journal of cardiology. 2009, Vol 104, Num 2, pp 151-157, issn 0002-9149, 7 p.Article

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction : An analysis of the valsartan in acute myocardial infarction trial (VALIANT)MCMURRAY, John; SOLOMON, Scott; KØBER, Lars et al.Journal of the American College of Cardiology. 2006, Vol 47, Num 4, pp 726-733, issn 0735-1097, 8 p.Article

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPDSUZUKI, Hiromichi; KANNO, Yoshihiko; SUGAHARA, Soichi et al.American journal of kidney diseases. 2004, Vol 43, Num 6, pp 1056-1064, issn 0272-6386, 9 p.Article

Angiotensin II type 1 receptor blockersBURNIER, Michel.Circulation (New York, N.Y.). 2001, Vol 103, Num 6, pp 904-912, issn 0009-7322Article

A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertensionHEDNER, T; OPARIL, S; RASMUSSEN, K et al.American journal of hypertension. 1999, Vol 12, Num 4, pp 414-417, issn 0895-7061, 1Article

Angioedema and photosensitive rash induced by valsartanFRYE, C. B; PETTIGREW, T. J.Pharmacotherapy. 1998, Vol 18, Num 4, pp 866-868, issn 0277-0008Article

Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure I. Effects on left ventricular performance and neurohormonal systemsSPINALE, F. G; DE GASPARO, M; WHITEBREAD, S et al.Circulation (New York, N.Y.). 1997, Vol 96, Num 7, pp 2385-2396, issn 0009-7322Article